Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.08

-2.7%

Nov 14 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (1305)	1/15/1999 7:20:00 AM
From: Anthony Wong	Read Replies (1) of 1722

Researchers Develop Viagra Spray Friday January 15 3:33 AM ET By TIM WHITMIRE Associated Press Writer LEXINGTON, Ky. (AP) - Can't wait an hour for that kick from Viagra? Two researchers from the University of Kentucky say they've come up with a nasal spray that could cut the time it takes for Viagra to work to five to 15 minutes. ''We feel because of the nature of Viagra's use that people don't want to wait an hour for results,'' said Lewis Dittert, one of the researchers. The impotency treatment pill debuted spectacularly last year, leading to millions of prescriptions and almost as many jokes. Sales have leveled off. When used correctly, Viagra is extremely effective, allowing men to achieve an erection 60 to 70 percent of the time within an hour of taking the blue pills that sell for about $10 each. Dittert and his UK College of Pharmacy colleague, Anwar Hussein, say the nasal spray brings Viagra in contact with mucous membranes, getting the active ingredient, sildenafil, into the bloodstream more quickly. The pill must reach the small intestines before it can be absorbed. So far, the researchers say, they haven't been able to generate any interest from the drug's manufacturer, Pfizer Inc. (NYSE:PFE - news) ''They said, 'We're looking at it, we'll call you,''' Dittert said. ''We're not trying to horn in on their patent. We just think we've got a better mousetrap, and we think they ought to be interested in it.'' Pfizer spokeswoman Mariann Caprino said the company is ''always interested in advancing our medicines ... in a way that makes the medicine more patient-friendly. We certainly don't want to rule out any advance.''

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next